BRAF and neoplasm: In addition, increased tumor T‐cell infiltration in BRAF inhibitor‐treated patients disappears in biopsies collected after 15 days from treatment initiation, suggesting that tumor cells develop a ‘counter‐strike’ strategy to delete T cells (Deken et al., 2016).